Heritage Labs

Heritage Labs, now operating as Avet Pharmaceuticals, is a specialty pharmaceutical company that develops, manufactures, and markets generic and legacy branded prescription products for the U.S. market. As a subsidiary of Emcure Pharmaceuticals, the company manages a diverse portfolio of over 150 products across therapeutic categories such as oncology, cardiovascular health, metabolic diseases, and anti-infectives. Heritage Labs has historically expanded its presence through the strategic acquisition of Abbreviated New Drug Applications (ANDAs) and maintains robust capabilities in oral solids and complex injectables. In 2019, the company underwent a strategic rebranding to Avet Pharmaceuticals to unify its corporate identity and emphasize its commitment to providing high-quality, affordable healthcare solutions.